May 30, 2026 08:00AM
May 18, 2026 08:00AM
May 14, 2026 10:55AM
May 12, 2026 09:04AM
May 12, 2026 09:00AM
Apr 30, 2026 09:00AM
Apr 20, 2026 06:45AM FDA grants priority review to Astellas-Pfizer cancer drug application
Apr 20, 2026 06:45AM
Mar 19, 2026 06:45AM
Feb 27, 2026 10:04AM
Feb 27, 2026 10:00AM
Jan 8, 2026 10:30AM
Dec 17, 2025 06:45AM
Dec 10, 2025 06:30PM Astellas to Present New Clinical Data Across Its Gastrointestinal Cancers Portfolio at 2026 ASCO GI Cancers Symposium
Dec 5, 2025 08:00AM
Nov 21, 2025 01:24PM
Nov 21, 2025 01:24PM
Oct 23, 2025 08:00AM
Oct 22, 2025 08:00AM
Oct 21, 2025 07:30PM
Oct 21, 2025 07:30PM PADCEV™ (enfortumab vedotin-ejfv) Plus KEYTRUDA® (pembrolizumab) sBLA Granted FDA Priority Review for Treatment of Certain Patients with Muscle-Invasive Bladder Cancer
Oct 19, 2025 07:30PM
Oct 14, 2025 08:00PM
Oct 8, 2025 07:30PM
May 1, 2025 09:00AM
Feb 13, 2025 10:00AM
Feb 12, 2025 06:32PM
Jan 8, 2025 06:30PM U.S. FDA Confirms Class 1 Resubmission of the Supplemental New Drug Application for IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy
Dec 5, 2024 08:49AM
Nov 20, 2024 01:00PM
Oct 18, 2024 02:13PM
Oct 10, 2024 01:00PM
Oct 10, 2024 06:51AM
Sep 24, 2024 02:05AM
Sep 18, 2024 07:30PM Astellas Announces FDA Listing of DIGITIVA™ for the Management of Heart Failure
Sep 4, 2024 08:00AM
Aug 27, 2024 07:30PM
Jul 26, 2024 11:39AM
May 30, 2024 10:30PM
Apr 23, 2024 07:30PM
Mar 28, 2024 11:00AM
Mar 26, 2024 08:30AM Astellas Receives Permanent J-code for IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy
Mar 22, 2024 08:00AM
Mar 11, 2024 09:00AM
Feb 15, 2024 06:30PM
Feb 1, 2024 07:00AM
Jan 30, 2024 09:00PM
Jan 26, 2024 12:01PM
Jan 26, 2024 12:00PM European Medicines Agency Validates Type II Variation Application for PADCEV® (enfortumab vedotin) with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer
Jan 26, 2024 12:00PM

322,969 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All